Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Public Cancer Care by Implementing Precision Medicine in Norway A Multi-cohort Phase 2 Treatment Clinical Study Investigating Efficacy of Approved Drugs Outside Indication in Patients With Advanced Cancer

NCT04817956 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04817956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04817956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Public Cancer Care by Implementing Precision Medicine in Norway A Multi-cohort Phase 2 Treatment Clinical Study Investigating Efficacy of Approved Drugs Outside Indication in Patients With Advanced Cancer
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
April 1, 2021
Completion date
April 30, 2045
Enrollment
3,000 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cancer metastatic